You can view the research column published every month by SMC Laboratories.
2025.01.30
The STAM mouse model: a clinically relevant, spontaneous HCC model
Today, we would like to introduce a study published by our client using our STAMTM mouse model (Dow, et al. Pr…
READ MORE
2025.01.30
Effect of the gut-liver axis dysfunction in liver disease
Today, We would like to introduce the relationship between Metabolic Dysfunction-Associated Steatotic Liver Di…
READ MORE
2025.01.30
Drug Efficacy Studies in NASH Mouse Model_ Mesenchymal stem/stromal cell small extracellular vesicles
Today’s topic is Effective cell therapy and exosome for NASH treatment. I would like to introduce a stud…
READ MORE
2025.01.30
Preventing Liver Cancer by Improving the Intestinal Dysbiosis
Today, we would like to introduce a study case of drug efficacy evaluation study using our mouse model of live…
READ MORE
2025.01.30
Gut Microbiome As a Target For NASH Therapeutics Study
We introduce the development of drugs for Metabolic Dysfunction-Associated Steatohepatitis (MASH) focusing on …
READ MORE
2025.01.30
Drug efficacy study in NASH mouse model
Today we would like to introduce a paper published by our client using our non-alcoholic steatohepatitis (NASH…
READ MORE
2025.01.30
Introduction of the paper using NASH model mouse
One of our clients, Kagawa University, has published the results of a study using our non-alcoholic steatohepa…
READ MORE
2025.01.30
Drug Efficacy Studies in NASH Mouse Model_TGF-b neutralizing antibody
Today, we would like to introduce a study published by our client using our STAM™ mouse model (Okrah et al., n…
READ MORE
2025.01.30
Clinically correlated adipose tissue in liver disease model
MASH (Metabolic Dysfunction-Associated Steatohepatitis) is the progressive form of MASLD. The multiple …
READ MORE
2025.01.30
Relationship between DAMPs/PAMPs and pathogenesis of STAM mice
Today, we would like to share with you the correlation between our proprietary STAMTM model for NASH-HCC, and …
READ MORE
